The American pharmaceutical company Johnson & Johnson is lowering its profit forecast for 2024. Unexpectedly high costs related to acquisitions are behind the decision.
Johnson & Johnson is simultaneously reporting a 10 percent profit increase for the second quarter of the year, which was better than expected. The adjusted operating profit rises to 2.82 dollars per share, compared to the expected 2.71 dollars per share.
Sales increased by 4 percent to 22.4 billion dollars, which can be compared to an average forecast of 22.3 billion dollars according to a compilation made by the news agency Bloomberg.
For the full year, the company is lowering its forecast to an adjusted profit of 9.97-10.07 dollars per share. Previously, it was at 10.57-10.72 dollars. The sales forecast of 88.0-88.4 billion dollars is confirmed.
